Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Germany
  4. Deutsche Boerse AG
  5. KetamineOne Capital Limited
  6. Summary
    MY00   CA4925531028

KETAMINEONE CAPITAL LIMITED

(MY00)
 SummaryQuotesChartsNewsCompanyFinancials 
Quotes 5-day view   Delayed Quote. Delayed Deutsche Boerse Ag
07/27/2021 07/28/2021 07/29/2021 07/30/2021 08/02/2021 Date
1.02(c) 0.9(c) 0.935(c) 0.9(c) 0.86 Last
0 400 0 0 0 Volume
0.00% -11.76% +3.89% -3.74% -4.44% Change
More quotes
Estimated financial data (e)
Sales 2019 - - -
Net income 2019 -6,58 M -5,28 M -5,28 M
Net cash position 2019 3,59 M 2,88 M 2,88 M
P/E ratio 2019 -
Yield 2019 -
Sales 2020 - - -
Net income 2020 1,13 M 0,90 M 0,90 M
Net cash position 2020 4,71 M 3,78 M 3,78 M
P/E ratio 2020 -
Yield 2020 -
Capitalization 159 M 127 M 127 M
EV / Sales 2019 -
EV / Sales 2020 -
Nbr of Employees -
Free-Float 100%
More Financials
Company
KetamineOne Capital Limited, formerly Myconic Capital Corp. is Canada-based wellness company. The Company is focused on assisted therapy and psychedelic medicines. The Company operates healthcare clinics across North America. The Company provides services for plant medicines, psychedelics, and mental health care. The Company is building a network of clinics with patient experiences. It is also developing wearable... 
Sector
Phones & Handheld Devices
Calendar
-
More about the company
All news about KETAMINEONE CAPITAL LIMITED
07/28ALEAFIA HEALTH : Ketamine One Advances Research Capabilities via Controlled Subs..
AQ
07/22KETAMINEONE CAPITAL : Ketamine One's IRP Clinic Using Innovative NeuroCatch Plat..
AQ
07/07KetamineOne Capital Limited Announces Resignation of Robert Meister from the ..
CI
07/07Ketamine One Announces Executive Changes
CI
06/17Ketamine One Highlights Psychedelic Research and Announces New Clinical Trial
GL
06/15Ketamine One Closes Previously Announced Acquisition of Integrated Rehab and ..
GL
06/15Ketamineone Capital Limited Reports Earnings Results for the Third Quarter En..
CI
06/15Myconic Capital Corp. completed the acquisition of Integrated Rehab and Perfo..
CI
06/14KETAMINEONE CAPITAL : Ketamine One Appoints Loreto Grimaldi to Board of Director..
AQ
06/14Ketamine One Appoints Loreto Grimaldi to Board of Directors
CI
06/07KetamineOne Capital Limited Announces Appointment of Quang Henderson to its S..
CI
06/04KETAMINEONE CAPITAL LIMITED (DB : MY00) entered into an Arrangement Agreement fo..
CI
06/03Myconic Capital Corp. will Change its Name to KetamineOne Capital Limited
CI
06/01Myconic Capital Corp. Announces Appointments
CI
06/01Myconic Capital Becomes Ketamine One
GL
More news
News in other languages on KETAMINEONE CAPITAL LIMITED

- No features available -

More news
Chart KETAMINEONE CAPITAL LIMITED
Duration : Period :
KetamineOne Capital Limited Technical Analysis Chart | MY00 | CA4925531028 | MarketScreener
Income Statement Evolution
Managers and Directors
Adam Deffett CEO & VP-Capital Markets & Communications
Peter Nguyen Director & Chief Financial Officer
Mark H. Kimmins Chief Medical Officer
Keith White President-Clinic Operations
Hock Ghim Toh Independent Director
Sector and Competitors
1st jan.Capi. (M$)
KETAMINEONE CAPITAL LIMITED1,061.29%127
APPLE INC.9.93%2 411 090
SAMSUNG ELECTRONICS CO., LTD.-3.09%458 317
XIAOMI CORPORATION-23.64%81 753
WINGTECH TECHNOLOGY CO.,LTD10.42%21 064
SHENZHEN TRANSSION HOLDINGS CO., LTD.7.07%20 168